Skip to main content
. 2023 Sep 17;36:gzad008. doi: 10.1093/protein/gzad008

Fig. 2.

Fig. 2

Neutralization activity of anti-SARS-CoV-2 scFv-Fcs. (A) Selected antibodies were tested against authentic SARS-CoV-2 virus in full neutralization curves. (B) Anti-SARS-CoV-2 scFv-Fcs demonstrate a wide range of neutralization activity, with Abs 12 and 27 on the potent end and Abs 28 and 23 on the weak/non-neutralizing end. Bin 3 antibodies typically have the most potent activity and Bins 1-2 display considerably weaker activity.